Tuberous sclerosis complex (TSC) is associated with TSC1 or TSC2 gene mutations resulting in hyperactivation of the mTORC1 pathway. This mTORC1 activation is associated with abnormal tissue development and proliferation such that in the kidney there are both solid tumors and cystic lesions. This review summarizes recent advances in tuberous sclerosis complex nephrology and focuses on the genetics and cell biology of tuberous sclerosis complex renal disease, highlighting a role of extracellular vesicles and the innate immune system in disease pathogenesis.
Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES.
Renal lesion growth in children with tuberous sclerosis complex. J Urol1998;
160:141–5
2.
StillwellTJGomezMRKelalisPP.Renal lesions in tuberous sclerosis. J Urol1987;
138:477–81
3.
Bissler JJKingswoodJ.
Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review. Ther Adv Urol2016;
8:1–12
4.
ShepherdCWGomezMRLieJTCrowson CS.
Causes of death in patients with tuberous sclerosis. Mayo Clin Proc1991;
66:792–6
5.
Lux A, Calder N, Laugharne M, Osborne J, O’callaghan F.
Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol2017;
59:612–7
6.
CrinoPBNathansonKLHenskeEP.The tuberous sclerosis complex. N Engl J Med2006;
355:1345–56
Kingswood JC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D’Amato L, d’Auge`res G, de Vries PJ, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Marques R, Nabbout R, O’Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Yourouko S, Zonnenberg B and Jansen AC, on behalf of the TOSCA Consortium and TOSCA Investigators.
Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease awareness. Nephrol Dial Transplant2019;
34:502–8
9.
European Chromosome 16 Tuberous Sclerosis Consortium.Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell1993;
75:1305–15
10.
Ohta S, Imaizumi Y, Okada Y, Okano H, Kawakami Y.
Generation of human melanocytes from induced pluripotent stem cells. PLoS One2011;
6:10
11.
Wang A, Tang Z, Li X, Tsou DA, Li S.
Derivation of smooth muscle cells with neural crest origin from human induced pluripotent stem cells. Cells Tissues Organs2011;
195:5–14
12.
Yang M, Liu E, Tang L, Lei Y, Sun X, Hu J, Dong H, Yang SM, Gao M, Tang B.
Emerging roles and regulation of MiT/TFE transcriptional factors. Cell Commun Signal2018;
16:11
13.
Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW.
A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol2010;
34:1395–406
14.
HenskeEP.Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosomes Cancer2003;
38:376–81
15.
Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy Jr JP, Wang J, Kumaki F, Darling T, Moss J.
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci U S A2004;
101:17462–7
16.
Goncharova EA, Goncharov DA, Chisolm A, Spaits MS, Lim PN, Cesarone G, Khavin I, Tliba O, Amrani Y, Panettieri Jr RA, Krymskaya VP.
Interferon β augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation. Mol Pharmacol2008;
73:778–88
17.
Yue M, Pacheco G, Cheng T, Li J, Wang Y, Henske EP, Schuger L.
Evidence supporting a lymphatic endothelium origin for angiomyolipoma, a TSC2 L tumor related to lymphangioleiomyomatosis. Am J Pathol2016;
186:1825–36
18.
Filipa Goncalves A, Adlesic M, Brandt S, Hejhal T, Harlander S, Sommer L, Shakhova O, Wild PJ, Frew IJ.
Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells. Nat Commun2017;
8:1466
19.
Yan X, Shi L, Chen G, Zhang X, Liu B, Yue W, Pei X, Sun S.
Mesenchymal stem cell-like cells in classic renal angiomyolipoma. Oncol Lett2012;
4:398–402
20.
Siroky BJ, Yin H, Dixon BP, Reichert RJ, Hellmann AR, Ramkumar T, Tsuchihashi Z, Bunni M, Dillon J, Bell PD, Sampson JR, Bissler JJ.
Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy. Am J Physiol Renal Physiol2014;
307:F560–70
21.
Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K.
Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology2002;
225:78–82
22.
Beltramello A, Puppini G, Bricolo A, Andreis IA, el-Dalati G, Longa L, Polidoro S, Zavarise G, Marradi P.
Does the tuberous sclerosis complex include intracranial aneurysms? A case report with a review of the literature. Pediatr Radiol1999;
29:206–11
23.
Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, Welsh CT, Kwiatkowski DJ.
Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet1996;
59:400–6
24.
BrasierJLHenskeEP.Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest1997;
99:194–9
25.
BlaszakRTPotamanVSindenRR, et al.
DNA structural transitions within the PKD1 gene. Nucleic Acids Res1999;
27:2610–7
26.
LiuGBisslerJJSindenRR, et al.
Unstable spinocerebellar ataxia type 10 (ATTCT)·(AGAAT) repeats are associated with aberrant replication at the ATX10 locus and replication origin-dependent expansion at an ectopic site in human cells. Mol Cell Biol2007;
27. DOI: 10.1128/MCB.01276-07
27.
PatelHPLuLBlaszakRT, et al.
PKD1 intron 21: triplex DNA formation and effect on replication. Nucleic Acids Res2004;
32:1460–8
28.
DixonBLuLLChuA, et al.
RecQ and RecG helicases have distinct roles in maintaining the stability of polypurine·polypyrimidine sequences. Mutat Res – Res2008;
643:20–8
29.
DixonBPChuAHenryJ, et al.
Increased cancer risk of augmentation cystoplasty: possible role for hyperosmolal microenvironment on DNA damage recognition. Mutat Res –Res2009;
670:88–95
30.
DixonBPHenryJSirokyBJ, Chu A, Groen PA, Bissler JJ.
Cell cycle control and DNA damage response of conditionally immortalized urothelial cells. PLoS One 2020;77:1–10
31.
McConnachieDJStowJLMallettAJ.Ciliopathies and the kidney: a review. Am J Kidney Dis2020;1–10
32.
TaoYKimJSchrierRWEdelstein CL.
Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol2005;
16:46–51
33.
WeimbsT.Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?Cell Cycle2006;
5:2425–9
34.
BoehlkeCKotsisFPatelVBraeg S, Voelker H, Bredt S, Beyer T, Janusch H, Hamann C, Gödel M, Müller K, Herbst M, Hornung M, Doerken M, Köttgen M, Nitschke R, Igarashi P, Walz G, Kuehn EW.
Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol2010;
12:1115–22
35.
LaiYJiangY.Reciprocal regulation between primary cilia and mTORC1. Genes (Basel)2020;
11:711–26
36.
BellPDFitzgibbonWSasKStenbit AE, Amria M, Houston A, Reichert R, Gilley S, Siegal GP, Bissler J, Bilgen M, Chou PC, Guay-Woodford L, Yoder B, Haycraft CJ, Siroky B.
Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis. J Am Soc Nephrol2011;
22:839–48
37.
MaMTianXIgarashiPPazour GJ, Somlo S.
Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat Genet2013;
45:1004–12
38.
SilvaLMJacobsDTAllardBAFields TA, Sharma M, Wallace DP, Tran PV.
Inhibition of hedgehog signaling suppresses proliferation and microcyst formation of human autosomal dominant polycystic kidney disease cells. Sci Rep2018;
8:12
39.
SedgwickAED’Souza-SchoreyC.Wnt signaling in cell motility and invasion: drawing parallels between development and cancer. Cancers (Basel)2016;
8:1–15
40.
ArmourEACarsonRPEssKC.Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules. Am J Physiol Renal Physiol2012;
303:F584–92
41.
OndaHLueckAMarksPWWarren HB, Kwiatkowski DJ.
Tsc2(+/–) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest1999;
104:687–95
42.
ZhouJBrugarolasJParadaLF.Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1. Hum Mol Genet2009;
18:4428–41
43.
WilsonCBonnetCGuyCIdziaszczyk S, Colley J, Humphreys V, Maynard J, Sampson JR, Cheadle JP.
Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/– mice. Cancer Res2006;
66:7934–8
44.
BonsibSMBoilsCGokdenNGrignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C, Sangoi AR, Wilson J, Zhang PL.
Tuberous sclerosis complex: hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Pathol Res Pract2016;
212:972–9
45.
BadenasCTorraRPérez-OllerLMallolas J, Talbot-Wright R, Torregrosa V, Darnell A.
Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients. Eur J Hum Genet2000;
8:487–92
46.
BisslerJJZadjaliFBridgesDAstrinidis A, Barone S, Yao Y, Redd JR, Siroky BJ, Wang Y, Finley JT, Rusiniak ME, Baumann H, Zahedi K, Gross KW, Soleimani M.
Tuberous sclerosis complex exhibits a new renal cystogenic mechanism. Physiol Rep2019;
7:e13983
47.
BaroneSZahediKBrooksMHenske, EP, Yang, Y, Zhang, E, Bissler, JJ, Yu, JJ, Soleimani, M.
Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex. Proc Natl Acad Sci U S A 2021;118:e2020190118
PatelBPatelJChoJ-HManne S, Bonala S, Henske E, Roegiers F, Markiewski M.
Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex. Oncogene2015;
35:1–10
50.
ZadjaliFKumarPYaoYJohnson D, Astrinidis A, Vogel P, Gross KW, Bissler JJ. Tuberous sclerosis complex axis controls renal extracellular vesicle production and protein content. Int J Mol Sci2020;
21:1729–44
51.
KumarPZadjaliFYaoY, et al. Tsc gene locus disruption and differences in renal epithelial extracellular vesicles. Front Physiol12:630933. doi: 10.3389/fphys.2021.630933.
52.
LittleMGeorgasKPennisiD, et al.
Kidney development: two tales of tubulogenesis. Curr Top Dev Biol2010;
90:193–229
53.
EladariDChambreyRPeti-PeterdiJ.A new look at electrolyte transport in the distal tubule. Annu Rev Physiol2012;
74:325–49
54.
WallSM.Recent advances in our understanding of intercalated cells. Curr Opin Nephrol Hypertens2005;
14:480–4
55.
Al-AwqatiQGaoXB.Differentiation of intercalated cells in the kidney. Physiology (Bethesda)2011;
26:266–72
56.
BretonSAlperSLGluckSLSly WS, Barker JE, Brown D.
Depletion of intercalated cells from collecting ducts of carbonic anhydrase II-deficient (CAR2 null) mice. Am J Physiol – Ren Fluid Electrolyte Physiol1995;
269. DOI: 10.1152/ajprenal.1995.269.6.f761
57.
JeongHJeonUSKooBKim WY, Im SK, Shin J, Cho Y, Kim J, Kong YY.
Inactivation of notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice. J Clin Invest 2009;119:3290–300
58.
ChristensenBMMarplesDKimYHWang W, Frøkiaer J, Nielsen S.
Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol – Cell Physiol2004;
286:952–64
59.
KimW-YYNamSAChoiAKim YM, Park SH, Kim YK, Kim J.
Aquaporin 2-labeled cells differentiate to intercalated cells in response to potassium depletion. Histochem Cell Biol2016;
145:17–24
60.
MaMJiangYJ.Jagged2a-notch signaling mediates cell fate choice in the zebrafish pronephric duct. PLoS Genet2007;
3:0133–45
61.
BlomqvistSRVidarssonHFitzgeraldSJohansson BR, Ollerstam A, Brown R, Persson AE, Bergström G Gö, Enerbäck S.
Distal renal tubular acidosis in mice that lack the forkhead transcription factor Foxi1. Differences2004;
113. DOI: 10.1172/JCI200420665.1560
62.
GuoQWangYTripathiPManda KR, Mukherjee M, Chaklader M, Austin PF, Surendran K, Chen F.
Adam10 mediates the choice between principal cells and intercalated cells in the kidney. J Am Soc Nephrol2015;
26:149–59
63.
Sequeira-LopezMLSNagalakshmiVKLiMSigmund CD, Gomez RA.
Vascular versus tubular renin: role in kidney development. Am J Physiol Regul Integr Comp Physiol2015;
309:R650–7
64.
ChenLChouC-LKnepperMA.A comprehensive map of mRNAs and their isoforms across all 14 renal tubule segments of mouse. J Am Soc Nephrol2021;
32:897–912
65.
ZhangH-NaXuQ-QThakurAAlfred MO, Chakraborty M, Ghosh A, Yu XB.
Endothelial dysfunction in diabetes and hypertension: role of microRNAs and long non-coding RNAs. Life Sci2018;
213:258–68
66.
ZhangCZhangKHuangFFeng W, Chen J, Zhang H, Wang J, Luo P, Huang H.
Exosomes, the message transporters in vascular calcification. J Cell Mol Med2018;
22:4024–33
67.
SuraceAEAHedrichCM.The role of epigenetics in autoimmune/inflammatory disease. Front Immunol2019;
10:1–16
68.
DavidTLingSFBartonA.Genetics of immune-mediated inflammatory diseases. Clin Exp Immunol2018;
193:3–12
69.
SoosTJSimsTNBarisoniLLin K, Littman DR, Dustin ML, Nelson PJ.
CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int2006;
70:591–6
70.
ZimmermanKASongCJLiZLever JM, Crossman DK, Rains A, Aloria EJ, Gonzalez NM, Bassler JR, Zhou J, Crowley MR, Revell DZ, Yan Z, Shan D, Benveniste EN, George JF, Mrug M, Yoder BK.
Tissue-resident macrophages promote renal cystic disease. J Am Soc Nephrol2019;
30:1841–56
71.
HatoTEl-AchkarTMDagherPC.Sisters in arms: myeloid and tubular epithelial cells shape renal innate immunity. Am J Physiol Renal Physiol2013;
304:F1243–51
72.
CurtaleGRubinoMLocatiM.MicroRNAs as molecular switches in macrophage activation. Front Immunol2019;
10:1–13
73.
MehtaABaltimoreD.MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol2016;
16:279–94
74.
MedzhitovRPreston-HurlburtPJanewayCA.A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature1997;
388:394–7
75.
YuLWangLChenS.Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med2010;
14:2592–603
76.
BoschSYoungNAMignotGBach JM.
Epigenetic mechanisms in immune disease: the significance of toll-like receptor-binding extracellular vesicle-encapsulated microRNA. Front Genet2020;
11:578335
77.
Chodankar R, Kwang S, Sangiorgi F, et al. Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr Biol 2005;
15:561–5
